Yasuhiro Mori
Overview
Explore the profile of Yasuhiro Mori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujita K, Mori Y, Kakumae Y, Takeuchi N, Kanemoto K, Nishihara M
Schizophr Res
. 2024 Feb;
266:19-23.
PMID: 38364729
Purpose: This empirical study aims to investigate the efficacy of pre-emptive cryotherapy in reducing pain that is caused by the deltoid intramuscular (IM) injection of long-acting injectable (LAI) antipsychotics in...
2.
Mori Y, Yamamoto A, Nakagawa A, Hikima T, Isowaki A
Biol Pharm Bull
. 2023 May;
46(7):921-928.
PMID: 37164692
Intravitreal injection therapy of anti-vascular endothelial growth factor (VEGF) antibody or steroids is the mainstream for patients with age-related macular degeneration (AMD). However, since intravitreal injection is invasive administration, side...
3.
Mori Y, Takeuchi H, Tsutsumi Y
Ther Adv Psychopharmacol
. 2023 Jan;
12:20451253221139608.
PMID: 36601351
Plain Language Summary: . Visual Summary: .
4.
Takeuchi H, Mori Y, Tsutsumi Y
Ther Adv Psychopharmacol
. 2022 Oct;
12:20451253221117313.
PMID: 36312846
Plain Language Summary: . Visual Summary: .
5.
Sugita K, Mori Y, Kanemoto K, Sugita S
Sci Prog
. 2022 Aug;
105(3):368504221117067.
PMID: 36000301
Introduction: The present study was conducted to investigate the possible hematologic impact of long-term electroconvulsive therapy (ECT) in patients with drug-resistant schizophrenia and receiving clozapine therapy. Subjects And Methods: In...
6.
Jam F, Morimune T, Tsukamura A, Tano A, Tanaka Y, Mori Y, et al.
Sci Rep
. 2020 Oct;
10(1):18044.
PMID: 33093561
Cell competition is a cell-cell interaction mechanism which maintains tissue homeostasis through selective elimination of unfit cells. During early brain development, cells are eliminated through apoptosis. How cells are selected...
7.
Khasan A, Rondhi M, Mori Y, Kondo T
Data Brief
. 2020 Sep;
32:106168.
PMID: 32904271
Massive irrigation development has influenced the way farmers govern water user associations (WUAs) in Klambu Wilalung Irrigation District in Central Java, Indonesia. Recently, farmers adopt community-based () and provider-based ()...
8.
Uchida M, Mori Y, Akiba K, Miyasaka M, Hirano T, Ikesue H, et al.
Biol Pharm Bull
. 2020 Aug;
43(10):1577-1582.
PMID: 32801282
Bendamustine plays an especially important role as a treatment for non-Hodgkin lymphoma (NHL). However, patients administered bendamustine alone or in combination with rituximab (BR) may experience drug-associated skin toxicities that...
9.
Uchida M, Yamaguchi Y, Hosomi S, Ikesue H, Mori Y, Maegawa N, et al.
Biol Pharm Bull
. 2020 May;
43(8):1235-1240.
PMID: 32435013
We retrospectively obtained data of patient background and pretreatment characteristics from medical records and identified the predictive factors of febrile neutropenia (FN) in patients with non-small cell lung cancer (NSCLC)...
10.
Niinomi I, Hosohata K, Mori Y, Yamaguchi Y, Wakabayashi T, Uchida M, et al.
J Pharm Health Care Sci
. 2019 Oct;
5:21.
PMID: 31608149
Background: Infliximab (IFX) has changed the management of many life-threatening immune-mediated diseases. The high cost of IFX and its patent expiry have led to pharmaceutical companies developing a biosimilar; however,...